Dr. Guy T. Bernstein, MD

Dr. Bernstein practices at Midlantic Urology in Bryn Mawr, Pennsylvania.

Dr. Bernstein's NPI, 1639178551, was assigned on July 21, 2005. Dr. Bernstein graduated from Vagelos College of Physicians and Surgeons in 1982. Dr. Bernstein holds Pennsylvania license MD041200E.

Dr. Bernstein's primary practice is Midlantic Urology, at 245 Bryn Mawr Ave, Bryn Mawr, PA 19010 in Delaware County. The practice phone is (484) 530-0205.

Dr. Bernstein's primary practice is Midlantic Urology in Bryn Mawr, Pennsylvania. Dr. Bernstein is also affiliated with Bryn Mawr Hospital. The medical group on file is MidLantic Urology. Dmand AI also links Dr. Bernstein to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bernstein practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Bernstein's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Bernstein is board certified in urology by the American Board of Urology. Dr. Bernstein is licensed in Pennsylvania.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Bernstein treats.

CMS data shows 15,876 Medicare services from Dr. Bernstein across 39 procedure codes in 2024, for 1,284 Medicare patients. Medicare paid $479,329 for them.

CMS counts 1,284 Medicare patients who saw Dr. Bernstein in 2024. The largest group is 75 to 84, with 539 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bernstein's median patient age at 72, with 14% women.

In 2024, Dr. Bernstein wrote 2,300 Medicare Part D claims for 593 patients. 85% of them were for generic drugs. CMS names the drug for 2,198 of them, across 33 drugs with 11 or more claims each, at $1,472,341 in total drug cost. In 2023, CMS named 1,992 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Bernstein for performance year 2024, reported as part of a group. Dr. Bernstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bernstein as offering telehealth. CMS counts 47 procedures of prostate resection by Dr. Bernstein, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Bernstein, published from 2011 to 2021. The most frequent topics are Postoperative Complications, Prostatic Neoplasms and Urinary Bladder Neoplasms. Dr. Bernstein has published most often in J Urol. Dr. Bernstein's most frequent co-authors are Stuart B. Bauer, MD, Douglas Francis Beach, MD and Laurence H. Belkoff, DO.

Dmand AI links Dr. Bernstein to 2 clinical trials. Conditions studied include Non-Muscle Invasive Bladder Neoplasms and Urinary Bladder Neoplasms.

CMS Open Payments shows 908 general payments to Dr. Bernstein from 76 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 63% of the total. Janssen Pharmaceuticals, Inc paid the most, $8,167. It also lists 1 research payment totaling $2,186 in 2018.

Dmand AI lists 9 awards for Dr. Bernstein, most recently CMS Stage 1 EHR in 2012.

Dr. Bernstein graduated from Vagelos College of Physicians and Surgeons in 1982. Dr. Bernstein is a member of ACS.

Dr. Bernstein is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.